CalciMedica Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-34.36	-9.14	-35.82	-34.72	-44.09	-32.7
Depreciation & Amortization	0.06	0.05	0.52	0.4	0.3	0.18
Share-Based Compensation	12.04	1.81	5.38	1.79	0.74	0.35
Other Operating Activities	-3.47	-5.79	-1.57	-6.72	4.78	-0.36
Operating Cash Flow	-25.73	-11.76	-31.5	-32.06	-31.22	-28.22
Capital Expenditures	-0.08	-0	-0.49	-1.02	-0.61	-1.46
Change in Investments	8.96	0	11.24	-41.54	-20.02	0
Investing Cash Flow	8.88	-0	10.75	-42.56	-20.62	-1.46
Share Issuance / Repurchase	10.59	0.02	0.7	96.33	0.13	0.12
Debt Issued / Paid	0	8.46	0	0	0	0
Other Financing Activities	10.31	-	-	-4.16	54.74	41.9
Financing Cash Flow	20.9	8.48	0.7	92.17	54.87	42.02
Net Cash Flow	4.05	-3.29	-20.05	17.55	3.04	12.34
Free Cash Flow	-25.81	-11.76	-31.99	-33.09	-31.82	-29.68
Free Cash Flow Per Share	-5.75	-143.00	-21.13	-69.99	-337.51	-36.36

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).